Janssen is one of the pharmaceutical companies of Johnson & Johnson. The company’s mission is to make disease a thing of the past by transforming individual lives, and fundamentally change the way diseases are managed, interpreted, and prevented, through innovation. More than 30,000 employees worldwide work to develop and bring innovative, high-quality pharmaceutical products and services to patients and caregivers. In Norway, Janssen provides patient treatments through clinical trials and commercialization of the company’s pharmaceuticals within the therapeutic areas of hematology, oncology, immunology, neuroscience, pulmonary arterial hypertension and infectious diseases. The main office is located in Lysaker, Oslo, with around 55 employees.

Abbott understands that the first step to living one’s best life is through good health. Everything Abbott makes is designed to help do just that. That’s their commitment to building life-changing technologies that keep hearts healthy, nourish bodies at every stage of life, help people feel and move better, and bring information, medicines and breakthroughs to manage health. Today, 109,000 employees are working to make a lasting impact on health in the more than 160 countries they serve. Abbott Norge employs 58 people and is active in the areas of manufacturing, marketing, sales, diagnostics, diabetes, cardiovascular & neuromodulation.

Bristol Myers Squibb is a leading global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. The company’s employees work every day to transform patients’ lives through science. Bristol Myers Squibb in Norway has close to 45 dedicated employees with the majority working at the office located at Lysaker outside of Oslo.

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company deeply rooted in science and innovation that is transforming new ideas and discoveries into medicines for patients with serious illnesses. With a presence in approximately 100 countries worldwide, Amgen has reached millions of people in the fight against serious illnesses, focusing on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. Amgen’s medicines typically address diseases for which the number of effective treatment options is limited, or they are medicines that provide a viable option to what is otherwise available. In Norway, there are 23 employees within sales, marketing, health economy, and medical activities. Amgen Norway is certified as a Great Place to Work where employee Inclusion, Diversity and Belonging are high on the agenda.